학술논문
Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full-dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial
Document Type
Article
Author
Source
In The Lancet Gastroenterology & Hepatology May 2019 4(5):376-388
Subject
Language
ISSN
2468-1253